Year: 2012
Type: review
Abstract: Prostacyclin, or PGI(2), is an end product derived from the sequential metabolism of arachidonic acid via cyclooxygenase and PGI synthase (PGIS). The receptor for PGI(2), IP, can be found on a variety of cell types and signaling through this receptor exhibits broad physiological effects. Historically, PGI(2) has been understood to play a role in cardiovascular health, specifically having powerful vasodilatory effects via relaxation of smooth muscle and inhibiting of platelet aggregation. For these reasons, PGI(2) has a long history of use for the treatment of pulmonary arterial hypertension (PAH). Only recently, its importance as an immunomodulatory agent has been investigated. PGI(2) regulates both the innate and adaptive immune systems and its effects are, for the most part, thought to be anti-inflammatory or immunosuppressive in nature, which may have implications for its further clinical use.
Source: Mediators of Inflammation
DOI: 10.1155/2012/926968
Authors: Stacy L. Dorris, R. Stokes Peebles
Institution: Vanderbilt University
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,040
Awards: G1473384567, The Role of PGI2 in Allergic Inflammation, The Role of IL-17 in RSV-induced Mucus and Airway Responsiveness, G5028430063, G5088652642, Building Interdisciplinary Research Careers in Women's Health, The Role of Il-13 in Regulating Th17 Cytokine Production, G7046916795, G7289273501, G7408974461, G8239366344, G8322497565, The Structure and Function of the CRTH2 PDG2 Receptor, G8673323746, Viral and Host Determinants of Infant and Childhood Allergy and Asthma
OpenAlex ID: W2068594714
